RODGERS JAMES D,ARVANITIS ARGYRIOS G,STORAGE LOUIS,SHAO LIXIN,GLENN JOSEPH P,SHEPARD STACEY,WANG HAISHENG,FOLMER BEVERLY,ZHU WENYU
申请号:
ZA201108544
公开号:
ZA201108544B
申请日:
2011.11.21
申请国别(地区):
ZA
年份:
2013
代理人:
摘要:
The present invention relates to N-(hetero)aryl-pyrrolidine derivatives of Formula I: which are JAK inhibitors, such as selective JAK1 inhibitors, useful in the treatment of JAK-associated diseases including, for example, inflammatory and autoimmune disorders, as well as cancer.